Data / Form D filings / Continuity Biosciences, LLC
Continuity Biosciences, LLC: Form D filings
Continuity Biosciences, LLC, a biotechnology company in Bradenton, FL, filed 3 Form D notices with the SEC between 2024 and 2025. The latest, on August 19, 2025, reports $8.4 million sold of a $12 million offering to 13 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8476 LINDRICK LANE, Bradenton, FL, 34202
- Phone
- (919) 480-3892
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2029079
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 19, 2025 | New notice | $12,000,000 | $8,424,490 | $3,575,510 | 13 | Aug 12, 2025 | sec.gov |
| Jun 4, 2025 | New notice | $1,000,000 | $1,000,000 | 13 | May 28, 2025 | sec.gov | |
| Jul 2, 2024 | New notice | $5,000,000 | $2,450,000 | $2,550,000 | 10 | Jun 20, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael L. Fowler | Director | |
| Allen R. Weiss | Director | |
| Monica P. Reed | Director | |
| Joseph R. DeSimone | Director | |
| Ramakrishna Venugopalan | Executive Officer, Director | |
| Robert Whitehead | Director | |
| Josephine R. Torrente | Director |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
Every Form D from the week of Aug 18, 2025 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Continuity Biosciences, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.